AppFolio gains 6% after announced entry into S&P MidCap 400; Stoke Therapeutics near-doubles after new data from STK-001 studies in Dravet syndrome Check out this evening's top movers from around Wall Street, compiled by The Fly.
HIGHER AFTER EARNINGS
- Stoke Therapeutics (STOK) up 87.7% after earnings, new data from STK-001 study
ALSO HIGHER
- AppFolio (APPF) up 6.0% after entering S&P MidCap 400
- Inari Medical (NARI) up 3.0% after entering S&P SmallCap 600
- Amneal (AMRX) up 2.0% after getting FDA approval for ciprofloxacin, dexamethasone otic suspension
DOWN AFTER EARNINGS
- Westport Fuel Systems (WPRT) down 14.2%
- BuzzFeed (BZFD) down 12.0%
- eFFECTOR Therapeutics (EFTR) down 4.8%
ALSO LOWER
- Rexford Industrial Realty (REXR) down 3.4% after equity offering
- Outlook Therapeutics (OTLK) down 3.3% after selling stock for holders
Symbols:
STOK APPF NARI AMRX WPRT BZFD EFTR REXR OTLK Keywords: fly intel, wall street, afterhours, movers, top stories, stocks